Gene Details



MAOA and homologs in 3 species are found in 400 GeneSets:


- Entrez   - Ensembl   - GeneNetwork   - STRING   - Comparative Toxicogenomics Database  

Select gene sets below using the check boxes, and then add them to a project using the pull down below. You can also create a project using the pull down. To view a set, click on the GeneSetID:GeneSet Description shown in green below.
GS185131: GO:0044699 single-organism process
GS125569: olanzapine interacting genes (MeSH:C076029) in CTD
GS168433: MP:0002980 abnormal postural reflex
GS204629: GO:1901564 organonitrogen compound metabolic process
GS210096: GO:0032940 secretion by cell
GS850: Sey_Pax6_Int_Lin_Inc_Lin_Inc
GS35967: Striatum Gene expression correlates of Handling induced convulsion score in Males BXD
GS189855: GO:0043168 anion binding
GS170725: MP:0002566 abnormal sexual interaction
GS178461: GO:0009987 cellular process
GS193061: GO:0044444 cytoplasmic part
GS180185: GO:0009712 catechol-containing compound metabolic process
GS192624: GO:0043231 intracellular membrane-bounded organelle
GS122337: Iron, Dietary interacting genes (MeSH:D019266) in CTD
GS196560: GO:0019867 outer membrane
GS186743: GO:0043227 membrane-bounded organelle
GS191484: GO:0042443 phenylethylamine metabolic process
GS190997: GO:0044281 small molecule metabolic process
GS192041: GO:0043169 cation binding
GS171901: HP:0010985 Gonosomal inheritance
GS178388: GO:0055114 oxidation-reduction process
GS123265: Estradiol interacting genes (MeSH:D004958) in CTD
GS184926: GO:0001505 regulation of neurotransmitter levels
GS193268: GO:0005575 cellular_component
GS194039: GO:1901363 heterocyclic compound binding
GS188190: GO:0006807 nitrogen compound metabolic process
GS196934: GO:0065008 regulation of biological quality
GS168839: MP:0003106 abnormal fear-related response
GS164014: MP:0001410 head bobbing
GS195083: GO:0007267 cell-cell signaling
GS186433: GO:0019614 catechol-containing compound catabolic process
GS125587: Reactive Oxygen Species interacting genes (MeSH:D017382) in CTD
GS176385: HP:0001249 Intellectual disability
GS125757: Isoflavones interacting genes (MeSH:D007529) in CTD
GS181962: GO:0016491 oxidoreductase activity
GS176817: HP:0011446 Abnormality of higher mental function
GS191019: GO:0034641 cellular nitrogen compound metabolic process
GS163852: MP:0001544 abnormal cardiovascular system physiology
GS202188: GO:0044248 cellular catabolic process
GS190713: GO:0016021 integral to membrane
GS123595: Progesterone interacting genes (MeSH:D011374) in CTD
GS125959: Cisplatin interacting genes (MeSH:D002945) in CTD
GS123065: fenvalerate interacting genes (MeSH:C017690) in CTD
GS86494: Table S1: Hippocampus 17 K microarray data. [DRG]
GS207857: GO:0009058 biosynthetic process
GS204630: GO:1901565 organonitrogen compound catabolic process
GS165466: MP:0003632 abnormal nervous system morphology
GS178334: GO:0007267 cell-cell signaling
GS201023: GO:0071704 organic substance metabolic process
GS126989: Hydralazine interacting genes (MeSH:D006830) in CTD
GS169585: MP:0001413 abnormal response to new environment
GS196343: GO:0036094 small molecule binding
GS191106: GO:0044464 cell part
GS182174: GO:0031966 mitochondrial membrane
GS177404: GO:0005737 cytoplasm
GS201251: GO:0044424 intracellular part
GS199730: GO:0071466 cellular response to xenobiotic stimulus
GS188692: GO:0042135 neurotransmitter catabolic process
GS193718: GO:0044106 cellular amine metabolic process
GS198210: GO:0006584 catecholamine metabolic process
GS163457: MP:0005655 increased aggression
GS165461: MP:0001525 impaired balance
GS167839: MP:0003459 increased fear-related response
GS198965: GO:0031968 organelle outer membrane
GS210666: GO:0044106 cellular amine metabolic process
GS126899: Methyl Parathion interacting genes (MeSH:D008743) in CTD
GS167025: MP:0003953 abnormal hormone level
GS127095: Serotonin interacting genes (MeSH:D012701) in CTD
GS168688: MP:0004486 decreased response of heart to induced stress
GS123943: Curcumin interacting genes (MeSH:D003474) in CTD
GS123157: Carbamazepine interacting genes (MeSH:D002220) in CTD
GS209108: GO:0000166 nucleotide binding
GS124659: Metribolone interacting genes (MeSH:D015741) in CTD
GS182801: GO:0034311 diol metabolic process
GS192074: GO:1901575 organic substance catabolic process
GS203279: GO:0019614 catechol-containing compound catabolic process
GS196790: GO:0046903 secretion
GS185585: GO:0044710 single-organism metabolic process
GS188690: GO:0042133 neurotransmitter metabolic process
GS124987: Trinitrobenzenesulfonic Acid interacting genes (MeSH:D014302) in CTD
GS208978: GO:0043169 cation binding
GS199601: GO:0034311 diol metabolic process
GS178284: GO:0031090 organelle membrane
GS194922: GO:0051378 serotonin binding
GS124438: Astemizole interacting genes (MeSH:D016589) in CTD
GS35236: Striatum Gene expression correlates of Background startle response in Males BXD
GS177526: GO:0043176 amine binding
GS199800: GO:0016641 oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor
GS199603: GO:0034313 diol catabolic process
GS164126: MP:0001388 abnormal stationary movement
GS168650: MP:0005166 decreased susceptibility to injury
GS180156: GO:0065008 regulation of biological quality
GS36842: Whole Brain Gene expression correlates of Percentage of entries into closed arms of plus maze in Females & Males BXD
GS189484: GO:0023052 signaling
GS126983: Dopamine interacting genes (MeSH:D004298) in CTD
GS202766: GO:0050660 flavin adenine dinucleotide binding
GS189867: GO:0042417 dopamine metabolic process
GS196808: GO:0032501 multicellular organismal process
GS205552: GO:0042136 neurotransmitter biosynthetic process
GS182173: GO:0031967 organelle envelope
GS186744: GO:0043226 organelle
GS202715: GO:0035637 multicellular organismal signaling
GS169828: MP:0005386 behavior/neurological phenotype
GS180563: GO:0005741 mitochondrial outer membrane
GS198059: GO:0005740 mitochondrial envelope
GS182835: GO:0005622 intracellular
GS202415: GO:0044710 single-organism metabolic process
GS202468: GO:0070887 cellular response to chemical stimulus
GS182168: GO:0031968 organelle outer membrane
GS207903: GO:0044281 small molecule metabolic process
GS210176: GO:0042428 serotonin metabolic process
GS35939: Striatum Gene expression correlates of Handling induced convulsions 7 hrs after ethanol in Males BXD
GS167755: MP:0000783 abnormal forebrain morphology
GS194133: GO:0005737 cytoplasm
GS186790: GO:0006725 cellular aromatic compound metabolic process
GS210586: GO:0051641 cellular localization
GS185765: GO:0042430 indole-containing compound metabolic process
GS190968: GO:0042424 catecholamine catabolic process
GS194111: GO:0097159 organic cyclic compound binding
GS189860: GO:0043167 ion binding
GS184448: GO:0044425 membrane part
GS194556: GO:0031975 envelope
GS187747: GO:0019226 transmission of nerve impulse
GS163803: MP:0003631 nervous system phenotype
GS200341: GO:0051179 localization
GS206742: GO:0043167 ion binding
GS177814: GO:0031975 envelope
GS184446: GO:0044429 mitochondrial part
GS195082: GO:0007268 synaptic transmission
GS195668: GO:0042221 response to chemical stimulus
GS209010: GO:1901575 organic substance catabolic process
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
GS169391: MP:0002066 abnormal motor capabilities/coordination/movement
GS123769: 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester interacting genes (MeSH:C548651) in CTD
GS169390: MP:0002067 abnormal sensory capabilities/reflexes/nociception
GS181473: GO:0005488 binding
GS182999: GO:0016641 oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor
GS175526: HP:0000005 Mode of inheritance
GS180036: GO:0032501 multicellular organismal process
GS196930: GO:0065007 biological regulation
GS192512: GO:0003824 catalytic activity
GS206446: GO:1901160 primary amino compound metabolic process
GS189577: GO:1901160 primary amino compound metabolic process
GS207616: GO:0016020 membrane
GS185538: GO:0048037 cofactor binding
GS126374: Plicamycin interacting genes (MeSH:D008926) in CTD
GS127028: Mifepristone interacting genes (MeSH:D015735) in CTD
GS169643: MP:0000937 abnormal motor neuron morphology
GS179796: GO:0019867 outer membrane
GS185880: GO:0035637 multicellular organismal signaling
GS181666: GO:0019439 aromatic compound catabolic process
GS169392: MP:0002065 abnormal fear/anxiety-related behavior
GS201349: GO:0006836 neurotransmitter transport
GS198971: GO:0031966 mitochondrial membrane
GS197244: GO:0044237 cellular metabolic process
GS178333: GO:0007268 synaptic transmission
GS198755: GO:0016491 oxidoreductase activity
GS164023: MP:0001961 abnormal reflex
GS177409: GO:0005739 mitochondrion
GS186067: GO:0050877 neurological system process
GS167798: MP:0008775 abnormal heart ventricle pressure
GS175529: HP:0000001 All
GS124711: Genistein interacting genes (MeSH:D019833) in CTD
GS187517: GO:0006576 cellular biogenic amine metabolic process
GS193018: GO:0003008 system process
GS194138: GO:0005739 mitochondrion
GS209957: GO:0003001 generation of a signal involved in cell-cell signaling
GS184447: GO:0044424 intracellular part
GS206737: GO:0043168 anion binding
GS207862: GO:0009056 catabolic process
GS198455: GO:0019439 aromatic compound catabolic process
GS209863: GO:0050896 response to stimulus
GS123854: Cyclophosphamide interacting genes (MeSH:D003520) in CTD
GS197356: GO:0005741 mitochondrial outer membrane
GS186740: GO:0043229 intracellular organelle
GS168230: MP:0001354 increased aggression towards males
GS202597: GO:0042430 indole-containing compound metabolic process
GS205549: GO:0042133 neurotransmitter metabolic process
GS195036: GO:0031090 organelle membrane
GS175806: HP:0001417 X-linked inheritance
GS185584: GO:0044712 single-organism catabolic process
GS205551: GO:0042135 neurotransmitter catabolic process
GS208012: GO:0044464 cell part
GS127038: Procarbazine interacting genes (MeSH:D011344) in CTD
GS201252: GO:0044425 membrane part
GS210212: GO:0005575 cellular_component
GS135241: activity 2 (Actvty2, Published QTL Chr X)
GS201239: GO:0046483 heterocycle metabolic process
GS193131: GO:0019336 phenol-containing compound catabolic process
GS202633: GO:0023061 signal release
GS185928: GO:0050660 flavin adenine dinucleotide binding
GS184435: GO:0046483 heterocycle metabolic process
GS166445: MP:0001906 increased dopamine level
GS202414: GO:0044712 single-organism catabolic process
GS194262: GO:0043176 amine binding
GS201250: GO:0044429 mitochondrial part
GS190989: GO:0042420 dopamine catabolic process
GS35915: Cerebellum Gene expression correlates of Handling induced convulsions 4 hrs after ethanol in Males BXD
GS86732: Table S1: Morphine regulation of gene expression in the LC in WT, AC1 KO, and AC8 KO Genes Significantly Regulated by Morphine in AC8 KO [DRG] provisional
GS121384: Zeranol interacting genes (MeSH:D015029) in CTD
GS179580: GO:0036094 small molecule binding
GS125445: Phenobarbital interacting genes (MeSH:D010634) in CTD
GS125714: Tyramine interacting genes (MeSH:D014439) in CTD
GS166392: MP:0001440 abnormal grooming behavior
GS174500: HP:0000707 Abnormality of the nervous system
GS121403: Glycine Agents interacting genes (MeSH:D018684) in CTD
GS177310: GO:1901360 organic cyclic compound metabolic process
GS205470: GO:0009410 response to xenobiotic stimulus
GS171998: HP:0001939 Abnormality of metabolism/homeostasis
GS163192: MP:0004484 altered response of heart to induced stress
GS166703: MP:0003964 abnormal noradrenaline level
GS123101: aluminum maltolate interacting genes (MeSH:C067527) in CTD
GS182834: GO:0005623 cell
GS199201: GO:0031224 intrinsic to membrane
GS36411: Neocortex Gene expression correlates of Open Field - Total rears 5-10 minutes in Females BXD
GS197043: GO:0044282 small molecule catabolic process
GS121349: Diuron interacting genes (MeSH:D004237) in CTD
GS126537: Catecholamines interacting genes (MeSH:D002395) in CTD
GS199635: GO:0005622 intracellular
GS208542: GO:0018958 phenol-containing compound metabolic process
GS188786: GO:0008131 primary amine oxidase activity
GS164857: MP:0001362 abnormal anxiety-related response
GS196943: GO:0008152 metabolic process
GS213076: Genes with suggestive difference in (B6) vs (B6PF1 + PB6F1 + PWD) comparison
GS187146: GO:0044700 single organism signaling
GS185926: GO:0050662 coenzyme binding
GS124752: Moclobemide interacting genes (MeSH:D020912) in CTD
GS36426: Neocortex Gene expression correlates of Open Field - Total number of Rears in Females BXD
GS196941: GO:0008150 biological_process
GS168838: MP:0003107 abnormal response to novelty
GS176166: HP:0001256 Intellectual disability, mild
GS199634: GO:0005623 cell
GS164136: MP:0000001 mammalian phenotype
GS121595: Dexamethasone interacting genes (MeSH:D003907) in CTD
GS124695: arsenic trioxide interacting genes (MeSH:C006632) in CTD
GS169386: MP:0002063 abnormal learning/memory/conditioning
GS198970: GO:0031967 organelle envelope
GS122847: nickel sulfate interacting genes (MeSH:C029938) in CTD
GS164854: MP:0001360 abnormal social investigation
GS164948: MP:0001505 hunched posture
GS201256: GO:0044422 organelle part
GS204007: GO:0044700 single organism signaling
GS126171: Capsaicin interacting genes (MeSH:D002211) in CTD
GS127308: brofaromine interacting genes (MeSH:C038213) in CTD
GS198211: GO:0006586 indolalkylamine metabolic process
GS126276: pirinixic acid interacting genes (MeSH:C006253) in CTD
GS123270: cypermethrin interacting genes (MeSH:C017160) in CTD
GS187160: GO:0044707 single-multicellular organism process
GS126022: befloxatone interacting genes (MeSH:C090014) in CTD
GS124951: Atrazine interacting genes (MeSH:D001280) in CTD
GS124732: isoproturon interacting genes (MeSH:C028904) in CTD
GS193059: GO:0044446 intracellular organelle part
GS35890: Whole Brain Gene expression correlates of Number of entries into open arms of plus maze [Ethanol] in Females & Males BXD
GS166690: MP:0001357 increased aggression toward humans
GS205647: GO:0008131 primary amine oxidase activity
GS209564: GO:0043231 intracellular membrane-bounded organelle
GS170693: MP:0004215 abnormal myocardial fiber physiology
GS166559: MP:0001905 abnormal dopamine level
GS36381: Neocortex Gene expression correlates of Open Field - Total rears 10-15 minutes in Females BXD
GS171274: HP:0100543 Cognitive impairment
GS121174: cimoxatone interacting genes (MeSH:C026234) in CTD
GS209452: GO:0006810 transport
GS1132: Addiction candidate genes
GS164779: MP:0010754 abnormal heart left ventricle pressure
GS204608: GO:0019226 transmission of nerve impulse
GS204021: GO:0044707 single-multicellular organism process
GS213073: Genes with suggestive difference in (PB6F1) vs (B6PF1 + B6 + PWD) comparison
GS205047: GO:0006807 nitrogen compound metabolic process
GS165260: MP:0001392 abnormal locomotor behavior
GS170884: HP:0006919 Abnormal aggressive, impulsive or violent behavior
GS167759: MP:0000787 abnormal telencephalon morphology
GS182803: GO:0034313 diol catabolic process
GS187770: GO:1901565 organonitrogen compound catabolic process
GS125266: toloxatone interacting genes (MeSH:C010798) in CTD
GS206749: GO:0042417 dopamine metabolic process
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
GS165303: MP:0003822 decreased left ventricle systolic pressure
GS168931: MP:0001431 abnormal eating behavior
GS171621: HP:0100851 Abnormal emotion/affect behavior
GS194459: GO:0051234 establishment of localization
GS179211: GO:0007154 cell communication
GS169967: MP:0001408 stereotypic behavior
GS164949: MP:0001504 abnormal posture
GS180152: GO:0065007 biological regulation
GS185366: GO:0044248 cellular catabolic process
GS163569: MP:0002557 abnormal social/conspecific interaction
GS195081: GO:0007269 neurotransmitter secretion
GS35875: Whole Brain Gene expression correlates of Number of entries into closed arms of plus maze in Females & Males BXD
GS196963: GO:0009712 catechol-containing compound metabolic process
GS169095: MP:0004924 abnormal behavior
GS202899: GO:0050877 neurological system process
GS163101: MP:0008540 abnormal cerebrum morphology
GS202364: GO:0048037 cofactor binding
GS203594: GO:0043226 organelle
GS203381: GO:0009308 amine metabolic process
GS205045: GO:0006805 xenobiotic metabolic process
GS210002: GO:0044444 cytoplasmic part
GS202764: GO:0050662 coenzyme binding
GS165537: MP:0005376 homeostasis/metabolism phenotype
GS169396: MP:0002069 abnormal eating/drinking behavior
GS210579: GO:0051649 establishment of localization in cell
GS167622: MP:0002152 abnormal brain morphology
GS209960: GO:0003008 system process
GS136315: non-HDL QTL 2 (Nhdlq2, Published QTL Chr X)
GS167585: MP:0001417 decreased exploration in new environment
GS168958: MP:0003492 abnormal involuntary movement
GS192174: GO:0000166 nucleotide binding
GS203593: GO:0043227 membrane-bounded organelle
GS165463: MP:0001523 impaired righting response
GS165604: MP:0008503 abnormal spinal cord grey matter morphology
GS127127: Benzo(a)pyrene interacting genes (MeSH:D001564) in CTD
GS169230: MP:0001400 hyperresponsive
GS182404: GO:0031224 intrinsic to membrane
GS210000: GO:0044446 intracellular organelle part
GS127166: bisphenol A interacting genes (MeSH:C006780) in CTD
GS174131: HP:0002011 Abnormality of the central nervous system
GS169658: MP:0002572 abnormal emotion/affect behavior
GS194087: GO:0003674 molecular_function
GS126990: Hydrocarbons interacting genes (MeSH:D006838) in CTD
GS169388: MP:0002061 abnormal aggression-related behavior
GS177356: GO:0003674 molecular_function
GS207615: GO:0016021 integral to membrane
GS163227: MP:0003313 abnormal locomotor activation
GS203590: GO:0043229 intracellular organelle
GS122925: Sertraline interacting genes (MeSH:D020280) in CTD
GS177309: GO:1901363 heterocyclic compound binding
GS124534: Norepinephrine interacting genes (MeSH:D009638) in CTD
GS210075: GO:0019336 phenol-containing compound catabolic process
GS180264: GO:0044282 small molecule catabolic process
GS207876: GO:0042424 catecholamine catabolic process
GS164856: MP:0001363 increased anxiety-related response
GS180166: GO:0008152 metabolic process
GS206091: GO:0007610 behavior
GS171832: HP:0000118 Phenotypic abnormality
GS203886: GO:1901265 nucleoside phosphate binding
GS121871: 3-methoxymethyl-7-(4,4,4-trifluorobutoxy)-3,3a,4,5-tetrahydro-1,3-oxazolo(3,4-a)quinolin-1-one interacting genes (MeSH:C492672) in CTD
GS166381: MP:0001353 increased aggression towards mice
GS178173: GO:0051378 serotonin binding
GS122229: Monomethylhydrazine interacting genes (MeSH:D009002) in CTD
GS177382: GO:0097159 organic cyclic compound binding
GS204384: GO:0006576 cellular biogenic amine metabolic process
GS191610: GO:0018958 phenol-containing compound metabolic process
GS164724: MP:0001516 abnormal motor coordination/ balance
GS174505: HP:0000708 Behavioural/Psychiatric Abnormality
GS166216: MP:0005164 abnormal response to injury
GS168956: MP:0003491 abnormal voluntary movement
GS122980: Methamphetamine interacting genes (MeSH:D008694) in CTD
GS190714: GO:0016020 membrane
GS201740: GO:0001505 regulation of neurotransmitter levels
GS193232: GO:0042428 serotonin metabolic process
GS169957: MP:0001402 hypoactivity
GS195214: GO:0009987 cellular process
GS163934: MP:0001764 abnormal homeostasis
GS184452: GO:0044422 organelle part
GS199124: GO:0051716 cellular response to stimulus
GS122364: Harmaline interacting genes (MeSH:D006246) in CTD
GS203642: GO:0006725 cellular aromatic compound metabolic process
GS207923: GO:0034641 cellular nitrogen compound metabolic process
GS187023: GO:1901265 nucleoside phosphate binding
GS198263: GO:0005488 binding
GS181420: GO:0006584 catecholamine metabolic process
GS194040: GO:1901360 organic cyclic compound metabolic process
GS86932: Table S3: CORTEX 17K MICROARRAY [DRG]
GS206355: GO:0023052 signaling
GS163896: MP:0011479 abnormal catecholamine level
GS195977: GO:0007154 cell communication
GS165804: MP:0002862 altered righting response
GS164539: MP:0003360 abnormal depression-related behavior
GS125403: Diethylstilbestrol interacting genes (MeSH:D004054) in CTD
GS125949: Clorgyline interacting genes (MeSH:D003010) in CTD
GS210357: GO:0044249 cellular biosynthetic process
GS180452: GO:0044237 cellular metabolic process
GS189677: GO:0016638 oxidoreductase activity, acting on the CH-NH2 group of donors
GS164301: MP:0005418 abnormal circulating hormone level
GS181271: GO:0005740 mitochondrial envelope
GS208411: GO:0042443 phenylethylamine metabolic process
GS163724: MP:0000436 abnormal head movements
GS123768: Cyclosporine interacting genes (MeSH:D016572) in CTD
GS180164: GO:0008150 biological_process
GS163540: MP:0011396 abnormal sleep behavior
GS168995: MP:0009642 abnormal blood homeostasis
GS164952: MP:0001501 abnormal sleep pattern
GS169829: MP:0005385 cardiovascular system phenotype
GS207896: GO:0042420 dopamine catabolic process
GS167748: MP:0000788 abnormal cerebral cortex morphology
GS187769: GO:1901564 organonitrogen compound metabolic process
GS181422: GO:0006586 indolalkylamine metabolic process
GS121802: Epinephrine interacting genes (MeSH:D004837) in CTD
GS206554: GO:0016638 oxidoreductase activity, acting on the CH-NH2 group of donors
GS165465: MP:0003633 abnormal nervous system physiology
GS190954: GO:0009056 catabolic process
GS166915: MP:0005322 abnormal serotonin level
GS209455: GO:0003824 catalytic activity
GS184218: GO:0071704 organic substance metabolic process
GS125506: Valproic Acid interacting genes (MeSH:D014635) in CTD
GS165366: MP:0002272 abnormal nervous system electrophysiology
GS186538: GO:0009308 amine metabolic process
GS167918: MP:0000955 abnormal spinal cord morphology
GS164220: MP:0002882 abnormal neuron morphology
GS201949: GO:0044699 single-organism process